Carlyle eyeing bid for Merck generics unit -source - Yahoo! News:
Merck's generics business was the world's third-largest in 2006 with sales of some 1.8 billion euros.
People familiar with the situation have told Reuters that U.S.-based Mylan Laboratories Inc. is among the potential bidders.
Iceland's Actavis and Ranbaxy Laboratories Ltd. of India have both said publicly they aim to buy it. Industry sources have also said Israel's Teva Pharmaceutical Industries Ltd. and India's Dr. Reddy's Laboratories Ltd. are also eyeing the operation."
This shouldn't effect drugs, prices or consumers at all. Merck just wants to focus on its core competency of high-margin new drug rather than low margin knock-offs.